FDAs Final Rule on Laboratory Developed Tests (LDTs)
On October 3, 2023, the FDA issued a proposed rule1 aimed at helping to ensure the safety and effectiveness of in vitro diagnostic products (IVDs) offered as LDTs, due to concerns that without FDA oversight false test results or false…
